# Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents

> **NCT01184443** · PHASE3 · TERMINATED · sponsor: **Children's Hospital of Eastern Ontario** · enrollment: 38 (actual)

## Conditions studied

- Eating Disorder

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT01184443
- **Lead sponsor:** Children's Hospital of Eastern Ontario
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2013-08
- **Final completion:** 2014-03
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2014-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184443, "Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01184443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*